NeurOptics, Inc. Completes Multiple Preferred Stock Financings

Represented NeurOptics, Inc. in its Series A, B and B-1 Preferred Stock financings. Neuroptics, Inc., the leader in the science of pupillometry, focuses on developing and commercializing innovative technologies that help to facilitate improved medical decision making and enable clinical research in the fields of critical care medicine, neurology, neurosurgery, emergency medicine, ophthalmology, and research.*